News Feature: Unique Oral Microbiome in Early and Pre-Clinical RA
An oral microbiome study of rheumatoid arthritis (RA) patients suggests that periodontal condition in patients with early rheumatoid arthritis (ERA) and individuals at risk of RA.
News Feature: Avacopan for ANCA Vasculitis Goes in Front of the FDA
An FDA advisory panel will consider whether to recommend approval of an oral C5a inhibitor for ANCA-associated vasculitis.
News Feature: Drug Monitoring Ineffective with Infliximab Treatment
A randomized trial compared TDM to no TDM in patients receiving infliximab for chronic IMIDs and found that TDM did not increase the odds of achieving remission.
Falls are not uncommon in #RA patients; significant risk factors for falls include being elderly, un-married, higher pain scores, reported dizziness taking psychotropic medications and having lower HRQoL scores https://t.co/a8qA7n68q5